-
Founded in:
2013-03-07 -
Country:
China -
Address:
No. 268, Tianrun Road, Wendeng Economic Development Zone, Weihai City, Shandong Province -
Tax NO.:
91371081062986928J -
Registered Funds:
360.5 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Flavoxate hydrochloride |
Extract from the above information
More
Extract from the above information |
3717-88-2 | 12 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Candesartan cilexetil |
Extract from the above information
More
Extract from the above information |
145040-37-5 | 49 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Loxoprofen sodium |
After being absorbed by the digestive tract, it is converted into active metabolites in the body. Its active metabolites exert analgesic, anti-inflammatory and antipyretic effects by inhibiting the synthesis of prostaglandins.
More
After being absorbed by the digestive tract, it is converted into active metabolites in the body. Its active metabolites exert analgesic, anti-inflammatory and antipyretic effects by inhibiting the synthesis of prostaglandins. |
80382-23-6 | 31 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Glipizide |
Glipizide is a second-generation sulfonylurea oral hypoglycemic drug. It mainly promotes the secretion of insulin by pancreatic β cells, especially the secretion of insulin stimulated by glucose; it also enhances the action of insulin, thereby effectively reducing blood glucose concentration and glycosylated hemoglobin; it can also improve hyperlipidemia, reduce triglyceride and cholesterol levels, and increase the ratio of high-density lipoprotein cholesterol in total cholesterol; it can also inhibit platelet aggregation and promote fibrinolysis, so it may have a certain preventive and therapeutic effect on vascular lesions. ① It promotes the secretion of insulin by pancreatic β cells, the prerequisite is that the pancreatic β cells still have a certain function of synthesizing and secreting insulin; ② By increasing the level of portal vein insulin or directly acting on the liver, it inhibits liver glycogenolysis and gluconeogenesis, and reduces the production and output of glucose by the liver.
More
Glipizide is a second-generation sulfonylurea oral hypoglycemic drug. It mainly promotes the secretion of insulin by pancreatic β cells, especially the secretion of insulin stimulated by glucose; it also enhances the action of insulin, thereby effectively reducing blood glucose concentration and glycosylated hemoglobin; it can also improve hyperlipidemia, reduce triglyceride and cholesterol levels, and increase the ratio of high-density lipoprotein cholesterol in total cholesterol; it can also inhibit platelet aggregation and promote fibrinolysis, so it may have a certain preventive and therapeutic effect on vascular lesions. ① It promotes the secretion of insulin by pancreatic β cells, the prerequisite is that the pancreatic β cells still have a certain function of synthesizing and secreting insulin; ② By increasing the level of portal vein insulin or directly acting on the liver, it inhibits liver glycogenolysis and gluconeogenesis, and reduces the production and output of glucose by the liver. |
29094-61-9 | 26 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Flunarizine dihydrochloride |
Extract from the above information
More
Extract from the above information |
30484-77-6 | 25 |